194 related articles for article (PubMed ID: 31134316)
1. MRI of Pediatric Orbital Masses: Role of Quantitative Diffusion-weighted Imaging in Differentiating Benign from Malignant Lesions.
Jaju A; Rychlik K; Ryan ME
Clin Neuroradiol; 2020 Sep; 30(3):615-624. PubMed ID: 31134316
[TBL] [Abstract][Full Text] [Related]
2. The roles of the diffusion-weighted imaging in orbital masses.
Phuttharak W; Boonrod A; Patjanasoontorn N; Peansukwech U; Sawanyawisuth K
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):753-758. PubMed ID: 28664638
[TBL] [Abstract][Full Text] [Related]
3. Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization.
Fatima Z; Ichikawa T; Ishigame K; Motosugi U; Waqar AB; Hori M; Iijima H; Araki T
Clin Neuroradiol; 2014 Jun; 24(2):129-34. PubMed ID: 23846020
[TBL] [Abstract][Full Text] [Related]
4. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
[TBL] [Abstract][Full Text] [Related]
5. Can diffusion-weighted imaging distinguish between benign and malignant pediatric liver tumors?
Caro-Domínguez P; Gupta AA; Chavhan GB
Pediatr Radiol; 2018 Jan; 48(1):85-93. PubMed ID: 28921384
[TBL] [Abstract][Full Text] [Related]
6. Characterization of orbital masses by multiparametric MRI.
Ro SR; Asbach P; Siebert E; Bertelmann E; Hamm B; Erb-Eigner K
Eur J Radiol; 2016 Feb; 85(2):324-36. PubMed ID: 26781137
[TBL] [Abstract][Full Text] [Related]
7. Role of Quantitative Diffusion-Weighted Imaging in Differentiating Benign and Malignant Orbital Masses.
Mundhada P; Rawat S; Acharya U; Raje D
Indian J Radiol Imaging; 2021 Jan; 31(1):102-108. PubMed ID: 34316117
[No Abstract] [Full Text] [Related]
8. Differentiation of Benign From Malignant Sinonasal Masses Using Diffusion Weighted Imaging and Dynamic Contrast Enhanced Magnetic Resonance Imaging.
Daga R; Kumar J; Pradhan G; Meher R; Malhotra V; Khurana N
Am J Rhinol Allergy; 2022 Mar; 36(2):207-215. PubMed ID: 34486401
[TBL] [Abstract][Full Text] [Related]
9. The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses.
Choi SY; Kim SH; Jang KM; Kang TW; Song KD; Moon JY; Choi YH; Lee BR
Br J Radiol; 2016 Jul; 89(1063):20160054. PubMed ID: 27164031
[TBL] [Abstract][Full Text] [Related]
10. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
[TBL] [Abstract][Full Text] [Related]
11. Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method.
Xu XQ; Hu H; Su GY; Liu H; Shi HB; Wu FY
Korean J Radiol; 2016; 17(5):650-6. PubMed ID: 27587953
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient in differentiation between malignant and benign breast masses: does size matter?
Wan CW; Lee CY; Lui CY; Fong CY; Lau KC
Clin Radiol; 2016 Feb; 71(2):170-7. PubMed ID: 26688549
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI.
Malek M; Pourashraf M; Mousavi AS; Rahmani M; Ahmadinejad N; Alipour A; Hashemi FS; Shakiba M
Asian Pac J Cancer Prev; 2015; 16(8):3407-12. PubMed ID: 25921153
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted imaging of orbital masses: multi-institutional data support a 2-ADC threshold model to categorize lesions as benign, malignant, or indeterminate.
Sepahdari AR; Politi LS; Aakalu VK; Kim HJ; Razek AA
AJNR Am J Neuroradiol; 2014 Jan; 35(1):170-5. PubMed ID: 23868150
[TBL] [Abstract][Full Text] [Related]
15. Benign and malignant skull-involved lesions: discriminative value of conventional CT and MRI combined with diffusion-weighted MRI.
Tu Z; Xiao Z; Zheng Y; Huang H; Yang L; Cao D
Acta Radiol; 2019 Jul; 60(7):880-886. PubMed ID: 29742920
[TBL] [Abstract][Full Text] [Related]
16. Utility of apparent diffusion coefficient (ADC) values in differentiating benign and malignant skull lesions with histopathological (HPE) correlation.
Mahendrakar AK; Kumaran SP; Reddy BN; Viswamitra S
J Clin Neurosci; 2022 Apr; 98():21-28. PubMed ID: 35131721
[TBL] [Abstract][Full Text] [Related]
17. Quantitative characterization of extraocular orbital lesions in children using diffusion-weighted imaging.
Maldonado FR; Princich JP; Micheletti L; Toronchik MS; Erripa JI; Rugilo C
Pediatr Radiol; 2021 Jan; 51(1):119-127. PubMed ID: 32901319
[TBL] [Abstract][Full Text] [Related]
18. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
[TBL] [Abstract][Full Text] [Related]
19. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
Partridge SC; Mullins CD; Kurland BF; Allain MD; DeMartini WB; Eby PR; Lehman CD
AJR Am J Roentgenol; 2010 Jun; 194(6):1664-73. PubMed ID: 20489111
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of combined diffusion-weighted imaging with dynamic contrast enhancement MRI in differentiating malignant from benign bone lesions.
Cao J; Xiao L; He B; Zhang G; Dong J; Wu Y; Xie H; Wang G; Lin X
Clin Radiol; 2017 Sep; 72(9):793.e1-793.e9. PubMed ID: 28545685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
